These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 154100)

  • 21. Renal transplantation between histocompatible donor-recipient pairs.
    Seigler HF; Stickel DL; Gunnells JC; McCoy R; Ward FE; Anderson EE; Amos DB
    Transplant Proc; 1972 Dec; 4(4):439-46. PubMed ID: 4264867
    [No Abstract]   [Full Text] [Related]  

  • 22. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine.
    Susskind BM; Chandrasekaran J
    J Immunol; 1987 Aug; 139(3):905-12. PubMed ID: 2955052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Busulfan-induced suppression of natural killer cell activity.
    Bhoopalam N; Price KS; Norgello H; Fried W
    Exp Hematol; 1985 Dec; 13(11):1127-32. PubMed ID: 2933271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets.
    Thiele DL; Lipsky PE
    J Immunol; 1986 Aug; 137(4):1399-406. PubMed ID: 3488348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipopolysaccharide-induced immunomodulation of the generation of cell-mediated cytotoxicity. I. Suppression of the development of cytotoxic lymphocytes.
    Vallera DA; Pflugfelder U; Schmidtke JR
    J Immunol; 1980 Feb; 124(2):635-40. PubMed ID: 6444314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro.
    Ware CF; Granger GA
    J Immunol; 1981 May; 126(5):1919-26. PubMed ID: 6452481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased frequency of kidney allograft rejection in recipients with cyclosporine and/or steroid-resistant lymphoid responses.
    Bowes LG; Dumble LJ; Francis DM; Macdonald IM; Clunie GJ; Kincaid-Smith P
    Transplant Proc; 1990 Oct; 22(5):2139-40. PubMed ID: 2145672
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of mixed leukocyte culture reactivity by sera from hemodialysis patients and transplant recipients as an indicator of isoimmunization.
    Suciu-Foca N; Buda JA; Thiem T; Almojera P; Reemtsma KB
    Lab Invest; 1974 Jul; 31(1):1-5. PubMed ID: 4276465
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of the donor-specific immune response by cyclosporin-A following renal transplantation.
    Keown PA; Stiller CR; Ulan RA; Sinclair NR; Rankin C; Carruthers G; Wall WJ
    Transplant Proc; 1981 Sep; 13(3):1669-72. PubMed ID: 6458135
    [No Abstract]   [Full Text] [Related]  

  • 31. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes.
    Thiele DL; Lipsky PE
    J Immunol; 1986 Feb; 136(3):1038-48. PubMed ID: 2934477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro monitoring of cadaver kidney donor pretreatment by lymphocyte culture.
    Jeffery JR; Guttmann RD; Charpentier B
    Clin Exp Immunol; 1976 Sep; 25(3):437-41. PubMed ID: 134860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of lymphokine-activated killer cell-mediated cytotoxicity by phorbol ester.
    Nishimura T; Burakoff SJ; Herrmann SH
    J Immunol; 1989 Mar; 142(6):2155-61. PubMed ID: 2646377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer activity in kidney allograft recipients.
    Moreau JF; Ythier A; Soulillou JP
    Transplant Proc; 1981 Sep; 13(3):1610-3. PubMed ID: 7029823
    [No Abstract]   [Full Text] [Related]  

  • 37. Transplantation in miniature swine. VII. Evidence for cellular immune mechanisms in hyperacute rejection of renal alografts.
    Kirkman RL; Colvin RB; Flye MW; Williams GM; Sachs DH
    Transplantation; 1979 Jul; 28(1):24-30. PubMed ID: 156420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
    Yaron I; Yaron R; Oluwole SF; Hardy MA
    Cell Immunol; 1996 Mar; 168(2):258-66. PubMed ID: 8640873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
    Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
    Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
    Steele TA; Brahmi Z
    J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.